Journal article

Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologists


Authors listGossec, L.; Bijlsma, J. W. J.; Bombardier, C.; Canhao, H.; Devlin, J.; Edwards, C. J.; Hamuryudan, V.; Kvien, T. K.; Leeb, B. F.; Martin-Mola, E. M.; Mielants, H.; Mueller-Ladner, U.; Ostergaard, M.; Pereira, I. A.; Ramos-Remus, C.; Zochling, J.; Dougados, Maxime

Publication year2011

Pages388-U180

JournalAnnals of the Rheumatic Diseases

Volume number70

Issue number2

ISSN0003-4967

DOI Linkhttps://doi.org/10.1136/ard.2010.128652

PublisherElsevier



Citation Styles

Harvard Citation styleGossec, L., Bijlsma, J., Bombardier, C., Canhao, H., Devlin, J., Edwards, C., et al. (2011) Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologists, Annals of the Rheumatic Diseases, 70(2), pp. 388-U180. https://doi.org/10.1136/ard.2010.128652

APA Citation styleGossec, L., Bijlsma, J., Bombardier, C., Canhao, H., Devlin, J., Edwards, C., Hamuryudan, V., Kvien, T., Leeb, B., Martin-Mola, E., Mielants, H., Mueller-Ladner, U., Ostergaard, M., Pereira, I., Ramos-Remus, C., Zochling, J., & Dougados, M. (2011). Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologists. Annals of the Rheumatic Diseases. 70(2), 388-U180. https://doi.org/10.1136/ard.2010.128652


Last updated on 2025-02-04 at 02:57